Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

類似資料

• In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
  著者:: Mascio, Carmela T. M., 等
  出版事項: (2012)
• In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
  著者:: Citron, Diane M., 等
  出版事項: (2012)
• Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
  著者:: Goldstein, Ellie J. C., 等
  出版事項: (2013)
• In Vitro Activity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
  著者:: Snydman, David R., 等
  出版事項: (2011)
• Activity of Ceftolozane-Tazobactam against a Broad Spectrum of Recent Clinical Anaerobic Isolates
  著者:: Snydman, David R., 等
  出版事項: (2014)